MicroRNA-101 Regulates Amyloid Precursor Protein Expression in Hippocampal Neurons*

The amyloid precursor protein (APP) and its proteolytic product amyloid beta (Aβ) are associated with both familial and sporadic forms of Alzheimer disease (AD). Aberrant expression and function of microRNAs has been observed in AD. Here, we show that in rat hippocampal neurons cultured in vitro, the down-regulation of Argonaute-2, a key component of the RNA-induced silencing complex, produced an increase in APP levels. Using site-directed mutagenesis, a microRNA responsive element (RE) for miR-101 was identified in the 3′-untranslated region (UTR) of APP. The inhibition of endogenous miR-101 increased APP levels, whereas lentiviral-mediated miR-101 overexpression significantly reduced APP and Aβ load in hippocampal neurons. In addition, miR-101 contributed to the regulation of APP in response to the proinflammatory cytokine interleukin-1β (IL-lβ). Thus, miR-101 is a negative regulator of APP expression and affects the accumulation of Aβ, suggesting a possible role for miR-101 in neuropathological conditions.

[1]  C. Barbato,et al.  MicroRNA‐92 modulates K(+) Cl(−) co‐transporter KCC2 expression in cerebellar granule neurons , 2010, Journal of neurochemistry.

[2]  Juan Nunez-Iglesias,et al.  Joint Genome-Wide Profiling of miRNA and mRNA Expression in Alzheimer's Disease Cortex Reveals Altered miRNA Regulation , 2010, PloS one.

[3]  J. Malter,et al.  Rck/p54 interacts with APP mRNA as part of a multi-protein complex and enhances APP mRNA and protein expression in neuronal cell lines , 2009, Neurobiology of Aging.

[4]  C. Barbato,et al.  Searching for MIND: MicroRNAs in Neurodegenerative Diseases , 2009, Journal of biomedicine & biotechnology.

[5]  A. Delacourte,et al.  MicroRNA regulation of Alzheimer's Amyloid precursor protein expression , 2009, Neurobiology of Disease.

[6]  Steven W. Flavell,et al.  Mef2-mediated transcription of the miR379–410 cluster regulates activity-dependent dendritogenesis by fine-tuning Pumilio2 protein levels , 2009, The EMBO journal.

[7]  D. Bartel.  MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[8]  I. Plante,et al.  MicroRNA-298 and MicroRNA-328 Regulate Expression of Mouse β-Amyloid Precursor Protein-converting Enzyme 1* , 2009, Journal of Biological Chemistry.

[9]  C. Barbato,et al.  Thinking about RNA? MicroRNAs in the brain , 2008, Mammalian Genome.

[10]  P. López-Casas,et al.  The expression patterns of genes involved in the RNAi pathways are tissue-dependent and differ in the germ and somatic cells of mouse testis. , 2008, Biochimica et biophysica acta.

[11]  A. Delacourte,et al.  Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/β-secretase expression , 2008, Proceedings of the National Academy of Sciences.

[12]  S. Sunkin,et al.  Specific expression of long noncoding RNAs in the mouse brain , 2008, Proceedings of the National Academy of Sciences.

[13]  S. Narumiya,et al.  Involvement of Prostaglandin E2 in Production of Amyloid-β Peptides Both in Vitro and in Vivo* , 2007, Journal of Biological Chemistry.

[14]  S. Dey,et al.  MicroRNA regulation of cyclooxygenase-2 during embryo implantation , 2007, Proceedings of the National Academy of Sciences.

[15]  D. Leake,et al.  Double-stranded regions are essential design components of potent inhibitors of RISC function. , 2007, RNA.

[16]  W. Lukiw,et al.  Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus , 2007, Neuroreport.

[17]  D. Selkoe,et al.  Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide , 2007, Nature Reviews Molecular Cell Biology.

[18]  Mihaela Zavolan,et al.  Effects of Dicer and Argonaute down-regulation on mRNA levels in human HEK293 cells , 2006, Nucleic acids research.

[19]  K. Sleegers,et al.  Promoter mutations that increase amyloid precursor-protein expression are associated with Alzheimer disease. , 2006, American journal of human genetics.

[20]  E. Reinke,et al.  Decoy mRNAs reduce β-amyloid precursor protein mRNA in neuronal cells , 2006, Neurobiology of Aging.

[21]  P. Stern,et al.  In vivo RNA interference demonstrates a role for Nramp1 in modifying susceptibility to type 1 diabetes , 2006, Nature Genetics.

[22]  Bryan Maloney,et al.  Mechanism of promoter activity of the β‐amyloid precursor protein gene in different cell lines: identification of a specific 30 bp fragment in the proximal promoter region , 2004, Journal of neurochemistry.

[23]  D. Srinivasan,et al.  Cell Type-Specific Interleukin-1β Signaling in the CNS , 2004, The Journal of Neuroscience.

[24]  M. Ciotti,et al.  Neuronal fibrillogenesis: amyloid fibrils from primary neuronal cultures impair long-term memory in the crab Chasmagnathus , 2003, Behavioural Brain Research.

[25]  Ming-Ming Zhou,et al.  Structure and conserved RNA binding of the PAZ domain , 2003, Nature.

[26]  C L Galli,et al.  Interleukin-1β Enhances NMDA Receptor-Mediated Intracellular Calcium Increase through Activation of the Src Family of Kinases , 2003, The Journal of Neuroscience.

[27]  Shinsei Minoshima,et al.  Identification of eight members of the Argonaute family in the human genome. , 2003, Genomics.

[28]  G. Hutvagner,et al.  A microRNA in a Multiple-Turnover RNAi Enzyme Complex , 2002, Science.

[29]  T. Tuschl,et al.  Identification of Tissue-Specific MicroRNAs from Mouse , 2002, Current Biology.

[30]  C. Broeckhoven,et al.  Transcriptional regulation of Alzheimer's disease genes: implications for susceptibility. , 2000, Human molecular genetics.

[31]  L. Murray,et al.  Association of interleukin‐1 gene polymorphisms with Alzheimer's disease , 2000, Annals of neurology.

[32]  Alfredo G. Tomasselli,et al.  Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity , 1999, Nature.

[33]  B. Liang,et al.  TGF-beta(1), regulation of alzheimer amyloid precursor protein mRNA expression in a normal human astrocyte cell line: mRNA stabilization. , 1999, Brain research. Molecular brain research.

[34]  P. Mcgeer,et al.  Distribution of cyclooxygenase-1 and cyclooxygenase-2 mRNAs and proteins in human brain and peripheral organs , 1999, Brain Research.

[35]  D. Selkoe,et al.  Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity , 1999, Nature.

[36]  C. Cahill,et al.  Translation of the Alzheimer Amyloid Precursor Protein mRNA Is Up-regulated by Interleukin-1 through 5′-Untranslated Region Sequences* , 1999, The Journal of Biological Chemistry.

[37]  S. Knapp,et al.  Prostaglandin E2 Stimulates Amyloid Precursor Protein Gene Expression: Inhibition by Immunosuppressants , 1999, The Journal of Neuroscience.

[38]  D. Trono,et al.  A Third-Generation Lentivirus Vector with a Conditional Packaging System , 1998, Journal of Virology.

[39]  G. Forloni,et al.  Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and β-amyloid production in cultures , 1995, Neuroscience Letters.

[40]  J. Malter,et al.  Amyloid precursor protein mRNA stability is controlled by a 29-base element in the 3'-untranslated region. , 1994, The Journal of biological chemistry.

[41]  H. W. Harris,et al.  Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[42]  W. Griffin,et al.  Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[43]  S. Prusiner,et al.  Nerve growth factor increases mRNA levels for the prion protein and the beta-amyloid protein precursor in developing hamster brain. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[44]  D. Selkoe,et al.  Gene dosage of the amyloid beta precursor protein in Alzheimer's disease. , 1987, Science.

[45]  A. Roses,et al.  Identification of miRNA Changes in Alzheimer's Disease Brain and CSF Yields Putative Biomarkers and Insights into Disease Pathways , 2008 .

[46]  D. Campion,et al.  APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy , 2006, Nature Genetics.

[47]  N. Dewji,et al.  Heat shock factor-1 mediates the transcriptional activation of Alzheimer's beta-amyloid precursor protein gene in response to stress. , 1996, Brain research. Molecular brain research.